Injectable ATX-101 Reduces Submental Fat
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy, Patient-Reported Outcomes and Safety Profile of ATX-101 (Deoxycholic Acid), an Injectable Drug for the Reduction of Unwanted Submental Fat: Results From a Phase III, Randomized, Placebo-Controlled Study
J Eur Acad Dermatol Venereol 2014 Mar 08;[EPub Ahead of Print], B Ascher, K Hoffmann, P Walker, S Lippert, U Wollina, B HavlickovaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.